Cargando…
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
Lysophosphatidylcholine (LPC) is increasingly recognized as a key marker/factor positively associated with cardiovascular and neurodegenerative diseases. However, findings from recent clinical lipidomic studies of LPC have been controversial. A key issue is the complexity of the enzymatic cascade in...
Autores principales: | Law, Shi-Hui, Chan, Mei-Lin, Marathe, Gopal K., Parveen, Farzana, Chen, Chu-Huang, Ke, Liang-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429061/ https://www.ncbi.nlm.nih.gov/pubmed/30845751 http://dx.doi.org/10.3390/ijms20051149 |
Ejemplares similares
-
Untargeted Lipidomic Profiling Reveals Lysophosphatidylcholine and Ceramide as Atherosclerotic Risk Factors in apolipoprotein E Knockout Mice
por: Law, Shi-Hui, et al.
Publicado: (2023) -
Role of Ceramidases in Sphingolipid Metabolism and Human Diseases
por: Parveen, Farzana, et al.
Publicado: (2019) -
An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System
por: Knuplez, Eva, et al.
Publicado: (2020) -
Metabolism of host lysophosphatidylcholine in Plasmodium falciparum-infected erythrocytes
por: Liu, Jiapeng, et al.
Publicado: (2023) -
Metabolic signatures in human follicular fluid identify lysophosphatidylcholine as a predictor of follicular development
por: Yang, Jihong, et al.
Publicado: (2022)